-
1
-
-
12344309924
-
¿Por qué vale la pena randomizar un estudio de terapia?
-
PEÑALOZA B, CANDIA R. ¿Por qué vale la pena randomizar un estudio de terapia? Rev Méd Chile 2004; 132: 1007-14.
-
(2004)
Rev Méd Chile
, vol.132
, pp. 1007-1014
-
-
Peñaloza, B.1
Candia, R.2
-
3
-
-
13544271035
-
Importancia de la intención de tratar y el seguimiento en la validez interna de un estudio clínico randomizado
-
CAPURRO D, GABRIELLI L, LETELIER LM. Importancia de la intención de tratar y el seguimiento en la validez interna de un estudio clínico randomizado. Rev Méd Chile 2004; 132: 1557-60.
-
(2004)
Rev Méd Chile
, vol.132
, pp. 1557-1560
-
-
Capurro, D.1
Gabrielli, L.2
Letelier, L.M.3
-
4
-
-
84858524685
-
Medidas del efecto de un tratamiento (I): Reducción absoluta del riesgo, reducción relativa del riesgo y riesgo relativo
-
ABRAIRA V. Medidas del efecto de un tratamiento (I): reducción absoluta del riesgo, reducción relativa del riesgo y riesgo relativo. SEMERGEN 2000; 26: 535-6.
-
(2000)
SEMERGEN
, vol.26
, pp. 535-536
-
-
Abraira, V.1
-
5
-
-
0028903054
-
Assessing the effects of treatment: Measures of association
-
JAESCHKE R, GUYATT G, SHANNON H, WALTER S, COOK D, HEDDLE N. Assessing the effects of treatment: measures of association. CMAJ 1995; 152: 351-7.
-
(1995)
CMAJ
, vol.152
, pp. 351-357
-
-
Jaeschke, R.1
Guyatt, G.2
Shannon, H.3
Walter, S.4
Cook, D.5
Heddle, N.6
-
6
-
-
0028220553
-
Completeness of reporting trial results: Effect on physicians' willingness to prescribe
-
BOBBIO M, DEMICHELIS B, GIUSTETTO G. Completeness of reporting trial results: effect on physicians' willingness to prescribe. Lancet 1994; 343: 1209-11.
-
(1994)
Lancet
, vol.343
, pp. 1209-1211
-
-
Bobbio, M.1
Demichelis, B.2
Giustetto, G.3
-
7
-
-
0028875866
-
Evidence based purchasing: Understanding results of clinical trials and systematic reviews
-
FAHEY T, GRIFFITHS S, PETERS TJ. Evidence based purchasing: understanding results of clinical trials and systematic reviews. BMJ 1995; 311: 1056-9.
-
(1995)
BMJ
, vol.311
, pp. 1056-1059
-
-
Fahey, T.1
Griffiths, S.2
Peters, T.J.3
-
8
-
-
11144246717
-
Understanding measures of treatment effect in clinical trials
-
AKOBENG AK. Understanding measures of treatment effect in clinical trials. Arch Dis Child 2005; 90: 54-6.
-
(2005)
Arch Dis Child
, vol.90
, pp. 54-56
-
-
Akobeng, A.K.1
-
9
-
-
4344559478
-
Tips for learners of evidence-based medicine: Relative risk reduction, absolute reduction and number needed to treat
-
BARRAT A, WYER PC, HATALA R, MCGINN T, DANS AL, KEITZ S ET AL. Tips for learners of evidence-based medicine: Relative risk reduction, absolute reduction and number needed to treat. CMAJ 2004; 171: 353-8.
-
(2004)
CMAJ
, vol.171
, pp. 353-358
-
-
Barrat, A.1
Wyer, P.C.2
Hatala, R.3
Mcginn, T.4
Dans, A.L.5
Keitz, S.6
-
10
-
-
85007745189
-
The odds ratio
-
BLAND JM, ALTMAN DG. The odds ratio. BMJ 2000; 320: 1468.
-
(2000)
BMJ
, vol.320
, pp. 1468
-
-
Bland, J.M.1
Altman, D.G.2
-
11
-
-
6344277332
-
Medidas del efecto de un tratamiento (II): Odds ratio y número necesario para tratar
-
ABRAIRA V. Medidas del efecto de un tratamiento (II): odds ratio y número necesario para tratar. SEMERGEN 2001; 27: 418-20.
-
(2001)
SEMERGEN
, vol.27
, pp. 418-420
-
-
Abraira, V.1
-
12
-
-
85133611835
-
Tips for teachers of evidence-based medicine: Relative risk reduction, absolute reduction and number needed to treat
-
BARRAT A, WYER PC, HATALA R, MCGINN T, DANS AL, KEITZ S ET AL. Tips for teachers of evidence-based medicine: Relative risk reduction, absolute reduction and number needed to treat. CMAJ 2004; 171: Online 1-8.
-
(2004)
CMAJ
, vol.171
, pp. 1-8
-
-
Barrat, A.1
Wyer, P.C.2
Hatala, R.3
McGinn, T.4
Dans, A.L.5
Keitz, S.6
-
13
-
-
0028908929
-
The number needed to treat: A clinically useful measure of treatment effect
-
COOK RJ, SACKETT DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995; 310: 452-4.
-
(1995)
BMJ
, vol.310
, pp. 452-454
-
-
Cook, R.J.1
Sackett, D.L.2
|